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Received 3 November 2014; revised 10 December 2014; accepted 14 December 2014AbstractObjectives: To evaluate outcomes in treating carcinoma of external auditory canal (EAC) and to analysis factors which effect the prognosis of
this disease.
Methods: A retrospectively review of 16 patients treated for carcinoma of EAC at our department between April 2000 and April 2014 was
conducted. All patients underwent surgical treatment and the diagnosis confirmed by pathological examination.
Results: There were adenoid cystic carcinoma (ACC) in 8 patients, squamous cell carcinoma (SCC) in 5 patients, adenocarcinoma (AC) in 2
patients, and verrucous carcinoma (VC) in 1 patient. The tumors were classified as Stage I in 4 cases, Stage II in 2 cases, Stage III in 3 cases, and
Stage IV in 7 cases. Five patients underwent extensive tumor resection (ETR), 2 patients underwent lateral temporal bone resection (LTBR), 5
patients underwent modified LTBR, 2 patients underwent subtotal temporal bone resection (STBR), and 2 patients underwent only open biopsy.
Besides, adjunctive procedures, including neck dissection, parotidectomy and pinna resection were performed when indicated. Ten patients
received postoperative radiotherapy. By the end of follow up, two patients had died of their disease, 2 lost to follow up, 2 survived with the
disease, and the rest survived disease-free. The median follow-up period was 24 months.
Conclusion: Complete tumor resection appears to be an effective treatment for carcinoma of the EAC. Patients with SCC seem to have worse
prognosis than those with ACC. Radiation therapy seems less effective for the disease than surgical treatment.
Copyright © 2014, PLA General Hospital Department of Otolaryngology Head and Neck Surgery. Production and hosting by Elsevier
(Singapore) Pte Ltd. All rights reserved.
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Carcinoma of the external auditory canal (EAC) is a rare
disease, with an annual incidence of approximately one to six
cases per million people which accounts for less than 0.2% of
all cancers in the head and neck area (Ting and Chun-fu, 2013;
Morris et al., 2012). These carcinomas can originate from* Corresponding author.
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Ltd. All rights reserved.EAC or be an extension of tumors from the auricle. Owing to
the rarity of this disease, experiences and reports in diagnosing
and managing this disease are scarce. Although cases of
cancer of the EAC or temporal bone have been reported pre-
viously (Gidley et al., 2010; Rose et al., 2013; McRackan
et al., 2014), most of the reports are limited to squamous
cell carcinoma (SCC). Comprehensive analyses of this disease
have been limited.
Moreover, there is not a standardized staging system for
EAC cancer so far. Yet an clearly defined staging system is
important for investigation of this disease. To date, the most
widely used system is the University of Pittsburgh staging
system (Morris et al., 2012; Gidley et al., 2010), which was
first described by Arriaga et al. (1990) and modified by Moodyy Head and Neck Surgery. Production and hosting by Elsevier (Singapore) Pte
147S. Zhen et al. / Journal of Otology 9 (2014) 146e150et al. (2000). The system is valid with respect to preoperative
assessment of tumor extent and survival prognosis.
The optimal management of patients with tumor of EAC
also remains a topic of debate and controversy. Resection
surgery with or without adjuvant radiotherapy is advocated by
most otorhinolaryngologist as the standard treatment for this
disease (Bacciu et al., 2013).
2. Methods and materials
Sixteen patients were seen and treated for carcinoma of the
EAC at our institution between April 2000 and April 2014. All
medical records were retrospectively reviewed for patient age,
sex, presenting symptoms, CT findings, disease stage, surgical
approach, histologic diagnosis, radiotherapy and follow up
findings. The tumors in the 16 patients were classified ac-
cording to the modified Pittsburgh staging system (Table 1)
(Morris et al., 2012; Moody et al., 2000).
In this study, the types of surgery performed on the 16
patients for the disease included open biopsy, extensive EAC
tumor resection, lateral temporal bone resection (LTBR),
modified LTBR and subtotal temporal bone resection (STBR).
Besides, adjunctive procedures, including neck dissection,
parotidectomy and pinna resection were performed when
indicated. Extensive resection of EAC tumors demands that
EAC skin, cartilages and a portion of bones which have the
possibility of being involved by the tumor be excised and that
the negative margins confirmed by intraoperative frozen bi-
opsy. The procedure of LTBR removes the bony canal en bloc
lateral to the facial nerve. The extent of this resection includes
the tympanic membrane, malleus, and incus. The stapes, facialTable 1
Modified Pittsburg staging system (Morris et al., 2012; Moody et al., 2000;
Moffat and Wagstaff, 2003).
Tumor Description
T1 Tumor limited to the EAC without bony erosion or
evidence of soft tissue involvement.
T2 Tumor limited to the EAC with bone erosion (not full
thickness) or limited soft tissue involvement (G0.5 mm).
T3 Tumor eroding the osseous EAC (full thickness)
with limited soft tissue involvement (G5 mm) or
tumor involving the middle ear and/or mastoid.
T4 Tumor eroding the cochlea, petrous apex, medial
wall of the middle ear, carotid canal, jugular
foramen, or dura; or tumor with extensive soft
tissue involvement (95 mm), such as involvement
of temporomandibular joint or styloid process; or
with evidence of facial paresis.
Lymph nodes
N0 No regional nodes identified
N1 Single ipsilateral regional node <3 cm in size
N2a Single ipsilateral regional node 3e6 cm in size.
N2b Multiple ipsilateral nodes
N2c Bilateral or contralateral nodes
N3 Node >6 cm
Tumor stage
Stage I T1 N0
Stage II T2 N0
Stage III T3 N0
Stage IV T4 N0 and T1-T4 Nþnerve, and inner ear structures are preserved. A modified
LTBR removes the EAC, leaving the uninvolved tympanic
membrane intact. Subtotal temporal bone resection (STBR)
extends the dissection into the labyrinth, the cochlea, or both.
The frozen-section pathology was used to estimate the safe
margin in all types of surgery.
The goal of the surgery was to extirpate disease, achieve a
negative margin and minimize morbidity and mortality. The
choice of surgical approach was based on the extent of tumor
involvement determined via physical examination, imaging
studies and pathology tests. Extensive tumor resection was
chosen for patients without bone erosion. LTBR or modified
LTBR was chosen for patients with limited EAC bone erosion
(not full thickness) and no involvement of tympanic cavity.
When the medial border of tumor was not closely adjacent to
the tympanic membrane, the modified LTBR was our first
choice. STBR was performed when tumor extended into the
tympanic cavity. Neck dissection, parotidectomy and pinna
resection were selected if involvement of cervical lymph node,
parotid gland or pinna was suspected. Beyond that, radio-
therapy was chosen as an adjuvant therapy for patients with
stage III/IV tumors. Furthermore, radiotherapy was also cho-
sen as the main treatment for patients who refused or were
unsuited for a resection surgery.
3. Results
The characteristics of the 16 patients including age, sex,
pathological diagnosis, presenting symptoms, CT findings,
tumor stage, surgery approach and adjunctive therapy, as well
as treatment outcomes, are listed in Table 2.3.1. Clinical dataThere were 5 males and 11 females who were enrolled in
this study. All of the tumors originated from the EAC, except 1
which extended from the pinna. The age of these patients
ranged from 29 to 72 years at the time of surgery, and the
median age was 49.5 years. Most of them (12/16) were older
than 40 years, and only 4 patients were 40 years old or
younger.3.2. HistopathologyAll patients received pathological examination. Tumor
types included adenoid cystic carcinoma (ACC, n ¼ 8), SCC
(n ¼ 5), adenocarcinoma (AC, n ¼ 2) and verrucous carci-
noma (VC, n ¼ 1). Among the 5 ACCs, 2 were well-
differentiated and 3 were moderately differentiated. Within
the subset of 4 cases that received parotidectomy and/or neck
dissection, 2 had cervical lymph node metastases, and none
had pathologic evidence of parotid invasion.3.3. SymptomsOtorrhea was the most common presenting symptom,
occurring in 11 patients, followed by otalgia (n ¼ 9), hearing
Table 2
Clinical data of 16 cases of EAC carcinoma.
Patients/sex T stage Symptoms Histologic
diagnosis
Structures involved Radiotherapy Misdiagnosis Previous
surgical
treatment
Outcomes Follow-up
(mo)
01/F T1 Otalgia ACC EAC, no bone erosion No Otitis externa,
granulation
of EAC
None LFU 97
02/F T4 Otorrhea, ear stuffy SCC(Mod) Extensive soft tissue involvement (>0.5 cm), tumor involving
tympanic cavity and pinna.
Yes Otitis media Recurrent
disease
DOD 11
03/F T1 Otalgia ACC EAC, no bone erosion No Otitis externa,
papilloma
None LFU 48
04/F T4 Ear stuffy, tinnitus, otorrhea SCC(Well) Limited EAC bone erosion, extensive (>5 mm) soft tissue involvement Yes No None DOD 23
05/F T2 Otalgia ACC Limited EAC bone erosion, limited (<0.5 cm) soft tissue involvement No oTitis externa,
granulation
of EAC
Persistent
disease
NED 55
06/M T2N1M0 Otalgia, otorrhea,
hearing loss
SCC(Mod) Limited (<0.5 cm) soft tissue involvement, preauricular lymph
nodes metastasis, no bone erosion
Yes Otitis externa None NED 50
07/F T1 Otalgia ACC EAC, no bone erosion No Otitis externa None NED 39
08/F T4 Otalgia, tinnitus, otorrhea,
hearing loss
ACC Tumor eroding the osseous EAC and the middle ear, with
involvement of TMJ
Yes Cholesteatoma Persistent
disease
AD 35
09/F T4 Otalgia, tinnitus, otorrhea,
hearing loss, ear stuffy
ACC Tumor with extensive (>5 mm) soft tissue involvement,
eroding the osseous EAC but not full thickness.
Yes Neuralgia None NED 32
11/M T3 Otorrhea, hearing loss AC(Poor) Tumor involving mastoid Yes Granulation
of EAC
Persistent
disease
NED 24
12/F T2 Otorrhea SCC(Well) Limited EAC bone erosion, limited (<0.5 cm) soft tissue involvement No No None NED 14
13/M T4N1M0 Otorrhea,ear stuffy,
hearing loss
SCC(Mod) Tumor eroding the osseous EAC (full thickness), middle ear and parotid. Yes No Recurrent
disease;
2times
AD 13
14/M T1 Otalgia ACC EAC, no bone erosion No No None NED 8
15/F T3 Otorrhea, ear stuffy,
hearing loss
VC Tumor eroding the osseous EAC (full thickness) and the tympanic cavity. Yes Papilloma Persistent
disease
NED 6
16/M T4 Otalgia, tinnitus, otorrhea,
hearing loss, ear stuffy,
headache
ACC Extensive (>5 mm) soft tissue involvement no bone erosion. Yes Otitis media None NED 5
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149S. Zhen et al. / Journal of Otology 9 (2014) 146e150loss (n ¼ 8), ear stuffiness (n ¼ 5), tinnitus (n ¼ 4), and
headache (n ¼ 1). None had facial paralysis at the time of
presentation. External auditory canal mass was discovered in
all patients at physical examination. In the 8 patients with
ACC, all had otalgia and 3 had otorrhea. In the 5 patients with
SCC, all presented with otorrhea, but only one complained of
otalgia.3.4. MisdiagnosisIn this series of 16 cases, 11 had been misdiagnosed in the
past. Five were diagnosed as otitis externa, 2 as chronic sup-
purative otitis media and 2 as papilloma in spite of the
attempted biopsy. Other misdiagnoses included cholesteatoma,
EAC granulation and neuralgia. Six patients had been previ-
ously surgically treated, of them 2 presented with recurrent
cancer despite the “complete” resection, and 4 with persistent
cancer following “incomplete” resection.3.5. Stages of tumor
Fig. 1. A case of ACC in EAC. CT of temporal bone showing soft tissue
blocking the left external auditory canal without bony destruction.
Tumor staging was in accordance to the modified Pitts-
burgh staging system which determine tumor stage post-
operatively using imaging studies, intraoperative findings, and
pathology report. Tumor in our cases were Stage I in 4 cases,
Stage II in 2 cases, Stage III in 3 cases, and Stage IV in 7
cases, with 2 also showing N1 nodes involvement. No patients
had distant metastasis.3.6. ManagementAll but 2 patients underwent surgical tumor excision. Two
patients refused resection surgery, and received an open biopsy
and radiotherapy. Modified LTBR was performed in 5 cases
including 1 stage II ACC, 1 stage III AC, 1 stage II SCC, 1
stage IVACC, and 1 stage IV SCC. Five cases of ACC (4 stage
I and 1 stage IV) required only extensive tumor resection.
LTBR was performed in 1 SCC and 1 ACC case (both stage
IV), and Only 2 patients underwent STBR (1 with stage IV
SCC and 1 with stage III VC). Two patients (1 AC and 1 SCC)
underwent neck dissection. Once patient (with AC) underwent
superficial parotidectomy and 3 patients (1 with stage IV SCC,
1 with stage III AC and 1 with stage IVACC) underwent total
parotidectomy. Radiotherapy was performed in 10 patients
with stage IIIeIV tumors.
4. Follow up outcomes
There were no perioperative deaths in this series. Upon
their last follow-up, 2 patients with stage IV SCC relapsed and
subsequently died of the disease at 11 and 23 months after the
surgery, respectively. Two patients were lost to follow-up at 48
and 97 months, respectively, both with stage I ACC and having
received local EAC tumor resection. One patient relapsed at 40
months of follow up and received rescue LTBR. The 2 patients
who had only open biopsy survived with disease by their last
follow up (35 and 13 months, respectively). Facial paralysiswas seen in one of these two patients at 29 months of follow
up. Ten patients survived without evidence of disease at a
median time of follow up of 24 months (range from 5 to 55
months).
5. Discussion
Malignancy of EAC is a rare disease. The otolaryngologist
may encounter few or even none EAC tumors in his career.
Patients of such disease often initially present with nonspecific
symptoms, such as ear discharge and otalgia. Because of the
lack of specific clinical manifestations and minimal experi-
ence in diagnosing and managing this disease among many
ENT doctors, misdiagnosis of EAC carcinoma occurs
frequently, especially during its early stages (Ting and Chun-
fu, 2013).
Otorrhea and otalgia are the most common symptoms of
temporal bone tumors (Gidley, 2013). Because these symp-
toms are similar to those of otitis externa and chronic sup-
purative otitis media, EAC cancer is easily misdiagnosed as
those common otologic diseases. In this group of patients, the
rate of initial misdiagnosis was 68.8% (11/16), with the most
common (5/11) being otitis externa. Other misdiagnoses
included chronic suppurative otitis media, cholesteatoma,
papilloma, granulation and neuralgia. In the present study,
otalgia was more inclined to be present in patients with ACC
(8/8), compared to patients with SCC (1/5). But otorrhea was
more prevalent in patients with SCC (5/5) than those with
ACC (3/8). Otalgia in patients with ACC may be related to the
ability of philo-nerves of ACC (Liu et al., 2012).
Some articles suggest (Ting and Chun-fu, 2013; Gidley,
2013) that biopsy should be chosen for a pathological
150 S. Zhen et al. / Journal of Otology 9 (2014) 146e150diagnosis if EAC carcinoma is suspected, especially if a case
of otitis media or otitis externa does not respond to standard
therapy. However, the credibility of biopsy is doubtful. In this
study, 2 patients were initially misdiagnosed as papilloma by
biopsy, but were ultimately admitted for cancer of EAC based
on the surgical pathological findings. The reliability of biopsy
is closely related to the location and depth of specimen
collection. Another important element in the accurate biopsy
identification of EAC carcinoma is specimen size that should
be sufficient for accurate histopathological examination. So we
suggest that multiple biopsies or an open biopsy be conducted,
if EAC carcinoma is highly suspected. Additionally, CT and
MRI should be considered, which not only help to provide
information that can lead to an early diagnosis but are bene-
ficial to estimating the extend of disease. CT is good at
discovering bone erosion and MRI is excellent at showing the
soft tissue lesion. The two imaging modalities are comple-
mentary (Horowitz et al., 1994). If temporal bone erosion is
seen on a CT scan, the patient is highly likely to have a ma-
lignant carcinoma of the temporal bone. In this group of pa-
tients, bone erosion was seen in 12 patients by CT. For patients
without temporal bone erosion on CT scan, a temporal bone
MRI on may still be necessary and can reveal potential soft
tissue lesions. In this study, high-resolution temporal bone CT
scan in one patient showed a left external auditory canal filled
with soft tissue with no obvious bone destruction (Fig. 1), but
pathology showed stage IVACC because of the extensive soft
tissue invasion (>5 mm).
According to the literature (Gidley, 2013; Moffat and
Wagstaff, 2003; Fang-lu et al., 2011), SCCs are the most
commonly observed and account for 80% of the temporal bone
tumors, followed by ACC. Interestingly the result of our study
show that ACC was the most common (50%), with SCC being
the second most common (31%). The cause of our different
findings is unknown and may be related to the small study
sample size or racial differences.
Although recent studies reported that surgical resection was
the main treatment for EAC carcinoma, what types of surgery
should be used is still in debate. To ensure a negative margin,
Moffat et al. (Moffat and Wagstaff, 2005; Masterson et al.,
2014; Graham et al., 1984; Jimbo et al., 2011) suggested
that an aggressive primary surgical treatment should be used
even in an early stage tumor. Although there is an improve-
ment of prognosis in patients who have undergone TTBR, this
procedure is associated with significant morbidity which canseverely impair patient's quality of life. So our team does not
use this technique.
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